Haridwar and Rishikesh have cardiology services — angiography, stenting, and pacemakers — but no dedicated full-service CTVS cardiac surgery centre. For bypass surgery, valve replacement, aortic surgery, or paediatric heart surgery, patients from this region have two realistic options:

 

Route from Haridwar and Rishikesh to Yatharth Hospital

• From Haridwar: NH-58 → Roorkee → Muzaffarnagar → Meerut bypass → Ghaziabad → Noida-Greater Noida Expressway → Sector 110
• From Rishikesh: NH-58 toward Haridwar → then as above
• From Roorkee: NH-58 → 2.5 hours
• Distance: 230–250 km from Haridwar | 3–3.5 hours drive
• This is the same route used by Dehradun patients — Dehradun patients choosing Yatharth Hospital pass through Haridwar en route

Cardiac Surgery Available

Your Surgeon — Dr. Ved Prakash

Director, CTVS — Yatharth Super Speciality Hospitals, Greater Noida. MCh CTVS. 8+ years at Medanta, Narayana, and Sarvodaya. Every patient seen and operated on personally. Ayushman Bharat, CGHS, ECHS, and all major insurance accepted. Uttarakhand state health scheme — confirm empanelment at time of booking.

Start Without Travelling

1. WhatsApp angiogram / echo / CT to +91-9355255106 — pre-assessment provided
2. Online cardiac consultation available before making the trip
3. Call to confirm OPD slot before travelling

Frequently Asked Questions

Is there a cardiac surgeon near Haridwar for bypass surgery?

AIIMS Rishikesh is nearby but has 6–12 week elective waiting times. Yatharth Hospital, Greater Noida is 3 hours via NH-58 — full CTVS surgery with no waiting list and a senior named surgeon performing every operation.

How far is Yatharth Hospital from Haridwar?

230–250 km via NH-58, approximately 3–3.5 hours. The same national highway used by Dehradun patients travelling to Greater Noida.

Why choose Yatharth over AIIMS Rishikesh?

When the waiting list at AIIMS is 6–12 weeks for an elective procedure and the patient’s condition or insurance allows a private hospital — no waiting list, named senior surgeon, comparable clinical outcomes, and mid-tier accessible cost.